← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 31, 2019Last known activity
Aug 27, 2024
Acquired by Eli Lilly on Dec 15, 2020
Timeline
2010s
- Jan 1, 2017
Prevail Therapeutics— Founded
2020s
- Dec 15, 2020
Eli Lilly— Acquired By
Drugs by trial phase (8 distinct, 5 trials)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT06565195Lead sponsorPhase 1Aug 27, 2024
- NCT05487599Lead sponsorPhase 1/Phase 2Aug 31, 2022
- NCT04408625Study directorPhase 1/Phase 2Jun 30, 2020
- NCT04411654Study directorPhase 1/Phase 2Jun 30, 2020
- NCT04408625Lead sponsorPhase 1/Phase 2Jun 30, 2020
- NCT04411654Lead sponsorPhase 1/Phase 2Jun 30, 2020
- NCT04127578Study directorPhase 1/Phase 2Oct 31, 2019
- NCT04127578Lead sponsorPhase 1/Phase 2Oct 31, 2019
Details
- Founded
- New York, NY, US Jan 1, 2017
- Last known activity
- Aug 27, 2024